research use only

Elacestrant (RAD1901) Dihydrochloride Estrogen Receptor Degrader

Cat.No.S9629

Elacestrant (RAD1901) Dihydrochloride is an orally available selective estrogen receptor degrader (SERD) with IC50 of 48 nM and 870 nM for ERα and ERβ, respectively.
Jump to

Quality Control

Batch: S962901 DMSO]100 mg/mL]false]Water]25 mg/mL]false]Ethanol]6 mg/mL]false Purity: 99.96%
99.96

Solubility

In vitro
Batch:

DMSO : 100 mg/mL (188.12 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : 25 mg/mL

Ethanol : 6 mg/mL

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 531.56 Formula

C30H40Cl2N2O2

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 1349723-93-8 -- Storage of Stock Solutions

Synonyms N/A SMILES CCNCCC1=CC=C(C=C1)CN(CC)C2=C(C=CC(=C2)OC)C3CCC4=C(C3)C=CC(=C4)O

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

Targets/IC50/Ki
ERα
48 nM
ERβ
870 nM
In vitro

Elacestrant (RAD1901) Dihydrochloride is a selective estrogen receptor degradation (SERD), which inhibits expression of ERα and ERβ in cultured breast tumor cell lines, thus inhibits the cell proliferation in a dose-dependent manner.

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-08-07)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07242352 RECRUITING
Breast Cancer; HR+/HER2- Breast Cancer
Women's Cancer Study Group GmbH
2026-04-29 PHASE3
NCT05512364 RECRUITING
ER-positive Breast Cancer; HER2-negative Breast Cancer; Stage IIB Breast Cancer; Stage III Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
2023-12-15 PHASE3
NCT07753954 NOT_YET_RECRUITING
ER+ / HER2- Advanced Breast Cancer
Jules Bordet Institute
2026-09-13 PHASE2
NCT07222215 RECRUITING
Estrogen-receptor-positive Breast Cancer; Metastatic Breast Cancer; Breast Cancer; Hormone Receptor Positive Breast Cancer; Human Epidermal Growth Factor 2 Negative Carcinoma of Breast; HER2- Breast Cancer; ESR1 Gene Mutation; ER Wildtype; Breast Neoplasms
Kristina A. Fanucci
2026-01-16 PHASE2
NCT06120283 RECRUITING
Advanced Solid Tumor; Advanced Breast Cancer; Metastatic Breast Cancer; Hormone-receptor-positive Breast Cancer; Hormone Receptor Positive Breast Carcinoma; Hormone Receptor Positive Malignant Neoplasm of Breast; HER2-negative Breast Cancer; Hormone Receptor Positive HER-2 Negative Breast Cancer
BeOne Medicines
2023-12-01 PHASE1
NCT06492616 RECRUITING
Breast Cancer
Stemline Therapeutics, Inc.
2024-09-27 PHASE3

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map